Search Results - "Haluska, Marianne"
-
1
Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
Published in Journal of clinical oncology (20-07-2009)“…PURPOSE Primary CNS lymphoma (PCNSL) is confined to the CNS and/or the eyes at presentation and is usually initially treated with intravenous…”
Get full text
Journal Article -
2
Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot Study
Published in International journal of radiation oncology, biology, physics (01-02-2011)“…Purpose We evaluated dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging (DSC-MRI) using gadoteridol in comparison to the iron oxide…”
Get full text
Journal Article -
3
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study
Published in Neurosurgery (01-04-2007)“…Ferumoxytol, an iron oxide nanoparticle that targets phagocytic cells, can be used in magnetic resonance imaging of malignant brain tumors and can be…”
Get full text
Journal Article -
4
Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol
Published in Neuro-oncology (Charlottesville, Va.) (01-02-2011)“…This study aims to compare gadoteridol with ferumoxytol for contrast-enhanced and perfusion-weighted (PW) MRI of intracranial tumors. The final analysis…”
Get full text
Journal Article -
5
Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol versus gadoteridol: A pilot study
Published in International journal of radiation oncology, biology, physics (13-04-2010)Get full text
Journal Article -
6
Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma
Published in Leukemia & lymphoma (01-09-2007)“…Five patients with relapsed PCNSL were given chemo-immunotherapy (rituximab followed by carboplatin and methotrexate) with osmotic blood-brain barrier (BBB)…”
Get full text
Journal Article -
7
Osmotic blood-brain barrier modification for the treatment of malignant brain tumors
Published in Clinical journal of oncology nursing (01-06-2004)“…The blood-brain barrier (BBB) is a physiologic barrier that protects the brain from toxic substances, including most of the chemotherapeutic agents used today…”
Get full text
Journal Article -
8
-
9
Prophylaxis of amygdala kindling-induced epileptogenesis: comparison of a GABA uptake inhibitor and diazepam
Published in Epilepsy research (01-01-1987)“…The prophylactic effect of an inhibitor of synaptosomal GABA uptake, SK&F 89976-A (N-[4,4-diphenyl-3-butenyl]-nipecotic acid), on the development of amygdala…”
Get more information
Journal Article -
10
Prevention of amygdala kindling with an inhibitor of gamma-aminobutyric acid uptake
Published in Neuroscience letters (15-08-1986)“…A novel, specific inhibitor of gamma-aminobutyric acid (GABA) uptake, SKF 89976-A (N-[4,4-diphenyl-3-butenyl]-nipecotic acid), was administered daily (15…”
Get more information
Journal Article -
11
Lifetime lead intoxication: influence on the amygdaloid kindling model of epileptogenesis
Published in Toxicology (Amsterdam) (01-01-1985)“…The nature of amygdaloid kindled seizures was studied in adult rats which were intoxicated with lead starting in neonatal life. Lactating females were exposed…”
Get more information
Journal Article